Skip to content

LivaNova LIVN Debt-to-equity

Debt-to-equity at other companies

Abbott logo
AbbottABT
0.7×+0.4×
Haemonetics logo
HaemoneticsHAE
1.6×0.0×
Medtronic logo
MedtronicMDT
0.6×0.0×
ResMed logo
ResMedRMD
0.2×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.5×-0.1×

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on the most recent quarter.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's debt-to-equity?
LivaNova (LIVN) reported debt-to-equity of 0.3× in Q1 2026.
How has LivaNova's debt-to-equity changed year-over-year?
LivaNova's debt-to-equity decreased by 57.0% year-over-year, from 0.7× to 0.3×.
What is the long-term trend for LivaNova's debt-to-equity?
Over 5 years (2020 to 2025), LivaNova's debt-to-equity has grown at a -10.7% compound annual growth rate (CAGR), from 0.6× to 0.4×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.